Halozyme Therapeutics (HALO) Gross Margin (2009 - 2026)
Halozyme Therapeutics (HALO) reported Gross Margin of 83.54% for Q2 2026, down 2.23 percentage points from 85.77% a year earlier but up 4.57 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Gross Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Gross Margin came in at 82.42%, down 1.78 percentage points year-over-year; for FY2025, it was 83.62%, down 0.68 percentage points from FY2024.
- Gross Margin has a five-year change of -0.17 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 84.30% in FY2024 (+7.50 pp), 76.80% in FY2023 (-2.09 pp), 78.90% in FY2022 (-2.74 pp) and 81.64% in FY2021 (-2.16 pp).
- Five-year quarterly Gross Margin spans a low of 74.62% in Q3 2023 and a high of 86.42% in Q1 2022.
- Year over year, Gross Margin has now declined in each of the last three quarters, with an average year-over-year change of +1.15 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was Q4 2024 (a gain of 8.62 percentage points); the low point was Q1 2023 (a drop of 8.11 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 78.97% (Q1 2026), 82.56% (Q4 2025) and 84.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 83.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 83.27% |
| Jun 30, 2026 | 83.54% |
| Mar 31, 2026 | 78.97% |
| Dec 31, 2025 | 82.56% |
| Sep 30, 2025 | 84.41% |
| Jun 30, 2025 | 85.77% |
| Mar 31, 2025 | 81.73% |
| Dec 31, 2024 | 85.89% |
| Sep 30, 2024 | 82.96% |
| Jun 30, 2024 | 82.88% |
| Mar 31, 2024 | 85.54% |
| Dec 31, 2023 | 77.27% |
| Sep 30, 2023 | 74.62% |
| Jun 30, 2023 | 77.35% |
| Mar 31, 2023 | 78.31% |
| Dec 31, 2022 | 76.79% |
| Sep 30, 2022 | 77.36% |
| Jun 30, 2022 | 77.72% |
| Mar 31, 2022 | 86.42% |
| Dec 31, 2021 | 78.84% |
API Access
Halozyme Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();